Nina J. Karlin

5.5k total citations · 1 hit paper
47 papers, 4.1k citations indexed

About

Nina J. Karlin is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Nina J. Karlin has authored 47 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 21 papers in Oncology and 18 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Nina J. Karlin's work include Metabolism, Diabetes, and Cancer (17 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (7 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Nina J. Karlin is often cited by papers focused on Metabolism, Diabetes, and Cancer (17 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (7 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Nina J. Karlin collaborates with scholars based in United States, Singapore and Mexico. Nina J. Karlin's co-authors include Elizabeth J. Carey, D. Vucicevic, Sanford H. Barsky, Curtiss B. Cook, Heidi Kosiorek, Amylou C. Dueck, Matthew Buras, Holly L. Geyer, Robert C. Smallridge and Keith C. Bible and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Nina J. Karlin

46 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trastuzumab-Induced Hepatotoxicity: A Case Report

2013 3.4k citations Elizabeth J. Carey, Nina J. Karlin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nina J. Karlin United States	15	2.2k	1.4k	1.1k	969	555	47	4.1k
Yang Lü United States	35	1.9k 0.9×	1.9k 1.4×	906 0.8×	971 1.0×	723 1.3×	171	4.5k
Thomas Hatschek Sweden	29	2.4k 1.1×	1.1k 0.8×	1.9k 1.8×	956 1.0×	614 1.1×	100	4.5k
Roberto Iacovelli Italy	34	2.1k 1.0×	1.5k 1.1×	1.2k 1.1×	2.6k 2.7×	395 0.7×	224	4.6k
Teresa A. Goldin United States	4	1.9k 0.8×	2.1k 1.4×	1.3k 1.2×	1.2k 1.2×	268 0.5×	5	4.7k
Nithya Ramnath United States	33	1.5k 0.7×	1.4k 1.0×	666 0.6×	1.7k 1.7×	431 0.8×	123	4.1k
Christos Markopoulos Greece	33	2.5k 1.1×	1.0k 0.7×	1.7k 1.5×	615 0.6×	366 0.7×	198	4.7k
Theodoros Foukakis Sweden	33	2.1k 1.0×	1.4k 1.0×	1.5k 1.4×	726 0.7×	381 0.7×	135	4.1k
D. Vucicevic United States	9	1.8k 0.8×	1.2k 0.8×	981 0.9×	867 0.9×	544 1.0×	30	3.6k
Serena Di Cosimo Italy	35	3.1k 1.4×	1.8k 1.3×	1.5k 1.3×	1.0k 1.1×	939 1.7×	181	5.0k
Marzia Del Re Italy	34	1.6k 0.7×	1.5k 1.1×	1.3k 1.2×	1.6k 1.6×	394 0.7×	167	3.9k

Countries citing papers authored by Nina J. Karlin

Since Specialization

Citations

This map shows the geographic impact of Nina J. Karlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina J. Karlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina J. Karlin more than expected).

Fields of papers citing papers by Nina J. Karlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina J. Karlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina J. Karlin. The network helps show where Nina J. Karlin may publish in the future.

Co-authorship network of co-authors of Nina J. Karlin

This figure shows the co-authorship network connecting the top 25 collaborators of Nina J. Karlin. A scholar is included among the top collaborators of Nina J. Karlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina J. Karlin. Nina J. Karlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Karlin, Nina J., et al.. (2022). Cancer, Diabetes, Survival and Glycemic Control: A Large Multisite Analysis. Future Science OA. 8(9). FSO820–FSO820. 2 indexed citations

Mangold, Aaron R., et al.. (2021). Survival and Glycemic Control in Patients With co-existing Squamous Cell Carcinoma and Diabetes Mellitus. Future Science OA. 7(5). FSO683–FSO683. 5 indexed citations

Kusne, Yael, et al.. (2021). Implications of Neuroendocrine Tumor and Diabetes Mellitus on Patient Outcomes and Care: a Matched case–control Study. Future Science OA. 7(5). FSO684–FSO684. 6 indexed citations

Kusne, Yael, et al.. (2020). Mortality and Glycemic Control Among Patients With Diabetes Mellitus and Uterine Or Ovarian Cancer. Future Science OA. 7(3). FSO670–FSO670. 3 indexed citations

Karlin, Nina J., et al.. (2020). Assessing the Relationship Between Institutional Cancer and Diabetes Mortality Rates Using National Death Index Data. Future Science OA. 6(10). FSO633–FSO633. 2 indexed citations

Buras, Matthew, et al.. (2020). Survival and Glycemic Control in Patients with Coexisting Lymphoma and Diabetes: A Case–Control Analysis. Future Science OA. 7(1). FSO641–FSO641. 2 indexed citations

Mountjoy, Luke, et al.. (2020). Mortality and Glycemic Control Among Patients with Acute and Chronic Myeloid Leukemia and Diabetes: A Case–Control Study. Future Science OA. 7(1). FSO639–FSO639. 1 indexed citations

Yang, Jie, Javier F. Magrina, Paul M. Magtibay, et al.. (2020). Management and outcomes of primary vaginal Cancer. Gynecologic Oncology. 159(2). 456–463. 26 indexed citations

Karlin, Nina J., et al.. (2019). Survival and Glycemic Control in Patients With Coexisting Melanoma and Diabetes Mellitus. Future Science OA. 5(3). FSO368–FSO368. 8 indexed citations

10.

Parker, David M., et al.. (2018). Genomic Profiling Reveals Medullary Thyroid Cancer Misdiagnosed as Lung Cancer. Case Reports in Oncology. 11(2). 399–403. 1 indexed citations

11.

Karlin, Nina J., et al.. (2016). Pseudocirrhosis: A Case Series and Literature Review. Case Reports in Gastroenterology. 10(2). 381–391. 29 indexed citations

12.

Jatoi, Aminah, Carmen Radecki Breitkopf, Nathan R. Foster, et al.. (2014). A Mixed-Methods Feasibility Trial of Protein Kinase C Iota Inhibition with Auranofin in Asymptomatic Ovarian Cancer Patients. Oncology. 88(4). 208–213. 28 indexed citations

13.

Bible, Keith C., Vera J. Suman, Julian R. Molina, et al.. (2014). A multicenter international phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H.. Journal of Clinical Oncology. 32(15_suppl). 6026–6026. 2 indexed citations

14.

Karlin, Nina J., et al.. (2014). Implications of breast cancer with diabetes mellitus on patient outcomes and care. Diabetes Management. 4(5). 411–419. 17 indexed citations

15.

Karlin, Nina J., Amylou C. Dueck, & Curtiss B. Cook. (2012). Cancer with Diabetes: Prevalence, Metabolic Control, and Survival in an Academic Oncology Practice. Endocrine Practice. 18(6). 898–905. 33 indexed citations

16.

Bible, Keith C., Vera J. Suman, Michael E. Menefee, et al.. (2012). A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 97(9). 3179–3184. 131 indexed citations

17.

Karlin, Nina J., et al.. (2012). Multimodality therapy improves survival in elderly patients with locally advanced non-small cell lung cancer—A retrospective analysis. Journal of Geriatric Oncology. 3(2). 104–110. 7 indexed citations

18.

Vaidya, Rakhee, Richa Sood, Nina J. Karlin, & Aminah Jatoi. (2011). Benzodiazepine Use in Breast Cancer Survivors: Findings from a Consecutive Series of 1,000 Patients. Oncology. 81(1). 9–11. 11 indexed citations

19.

Barsky, Sanford H. & Nina J. Karlin. (2006). Mechanisms of Disease: breast tumor pathogenesis and the role of the myoepithelial cell. Nature Clinical Practice Oncology. 3(3). 138–151. 47 indexed citations

20.

Barsky, Sanford H. & Nina J. Karlin. (2005). Myoepithelial Cells: Autocrine and Paracrine Suppressors of Breast Cancer Progression. Journal of Mammary Gland Biology and Neoplasia. 10(3). 249–260. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact